Skip to main content
NUTXNutex Health Inc.Buy Now5.9·$185.84-1.43%

Nutex Health (NUTX) Q2 2026 earnings — TrendMatrix coverage

BEAT+89.3% vs estimateEPS $9.38 vs $4.95 estVerdict Buy (Wait)Strong Buy

Reported

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure

Event detail · Q2 2026

Key numbers

Reported EPS
$9.38
Estimate
$4.95
Surprise
+89.3%
Revenue (period 2026-06-30)
$210.8M
Score at report (before → after)
7.07.0/10

Revenue source: xbrl.

Report record · Q2 2026

How the report landed

Nutex Health (NUTX) beat the $4.95 estimate with diluted EPS of $9.38 — a large 89.3% upside surprise. TrendMatrix's engine moved from Buy (Wait) (7.0/10) to Strong Buy at 7.0/10 after the report.

Current read · as of 2026-08-23

Where TrendMatrix's rating stands now

TrendMatrix currently rates NUTX Strong Buy at 5.9/10.

3 of the last 4 quarters beat the estimate; this quarter's +89.3% surprise compares with a +79.9% four-quarter average. Next scheduled report: 2026-11-05.

What supports the rating

  • Strong earnings beat streak (3/4)
  • High-quality business

What argues against it

  • Concentration risk — Counterparty: HaloMD (exclusive IDR claims processor)
  • Weak growth

This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.

Current engine read

The levels TrendMatrix's engine tracks

Current price
$185.84
Entry target
$185.84
Price target
$240.12
Stop
$172.83
Upside to target
+29.2%
Reward-to-risk
1.9:1

Forward estimates sit below the trailing run-rate (9.1× forward vs 7.3× trailing) — consensus expects earnings to decline from here.

Model outputs from TrendMatrix’s engine as of 2026-08-23 — shown for context, not personalized investment advice.

Healthcare context

NUTX at TrendMatrix's latest read

Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.

Industry
Medical Care Facilities
Market cap
$1.27B
P/E (fwd)
9.1
P/E (ttm)
7.3
52-week range
$77.21$204.00
Off 52-week high
8.9%
RSI (14)
64
Volume vs avg
0.72×
Score today
5.9/10

Earnings figures are sourced from TrendMatrix’s pipeline (EPS: existing earnings extraction; revenue: SEC XBRL company facts where available, yfinance-provisional otherwise). Not a buy/sell rating, a price target, or investment advice — see the current verdict on the stock’s main page for TrendMatrix’s live read.

Home Stocks NUTX Earnings Q2 2026 earnings